Abstract
Recent studies have identified carbon monoxide (CO) as a potential therapeutic molecule for the treatment of inflammatory diseases including intestinal inflammation. In the present study, we explored the efficacy and the mechanisms of action of CO-releasing molecule (CORM)-A1 in T-cell transfer induced colitis model in mice. In addition, the impact of CORM-A1 on the T helper (Th) cell differentiation was evaluated using naïve CD4 + T cells isolated from the spleens in Balb/c mice. The results showed that CORM-A1 conferred protection against the development of intestinal inflammation and attenuated Th17 cell differentiation. Hence, the observed immunomodulatory effects of CORM-A1 could be useful for developing novel therapeutic approaches for managing intestinal inflammation through the regulation of Th17 differentiation.
Original language | English |
---|---|
Pages (from-to) | 1328-1335 |
Number of pages | 8 |
Journal | Free Radical Research |
Volume | 52 |
Issue number | 11-12 |
DOIs | |
Publication status | Published - 02-12-2018 |
Externally published | Yes |
All Science Journal Classification (ASJC) codes
- Biochemistry